Sort
48,018 grants matching “immunotherapy”
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$503,134Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
DKK2 regulates NK activation and tumor immunity
$503,046Dianqing Wu · Yale University · R01 · FY2022 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$502,945Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2016 · CA
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
$502,821Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Regulatory T cells in Autoimmune Disease
$502,820Charles Garrison Fathman · Brigham And Women'S Hospital · U19 · FY2009 · AI
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs
$502,807Namita Rout · Tulane University Of Louisiana · R33 · FY2021 · AI
The Adenosinergic Pathway in Tumor-derived Exosomes
$502,792Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Evaluation of immunotherapy-novel treatments in biochemically recurrent prostate
$502,778Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
$502,655Periasamy Selvaraj · Emory University · R01 · FY2016 · CA
Structural and functional characterization of protective antibodies induced in peanut oral immunotherapy
$502,640Sarita U Patil · Massachusetts General Hospital · R01 · FY2021 · AI
Structural and functional characterization of protective antibodies induced in peanut oral immunotherapy
$502,640Sarita U Patil · Massachusetts General Hospital · R01 · FY2022 · AI
Structural and functional characterization of protective antibodies induced in peanut oral immunotherapy
$502,640Sarita U Patil · Massachusetts General Hospital · R01 · FY2023 · AI
Structural and functional characterization of protective antibodies induced in peanut oral immunotherapy
$502,640Sarita U Patil · Massachusetts General Hospital · R01 · FY2024 · AI
Pro-tumorigenic functions of human DNA polymerases eta and kappa during genome duplication under physiological replication stress conditions
$502,632Kristin A Eckert · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2020 · CA
Exploring the potential of TET inhibition in cancer immunotherapy
$502,630Anjana Rao · La Jolla Institute For Immunology · R01 · FY2021 · CA
Exploring the potential of TET inhibition in cancer immunotherapy
$502,630Anjana Rao · La Jolla Institute For Immunology · R01 · FY2020 · CA
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
$502,627Yuri Sykulev · Thomas Jefferson University · U01 · FY2023 · AI
Identify the host genetic determinants of immune response and TB countrol
$502,621Ildiko Vanrhijn · Brigham And Women'S Hospital · U19 · FY2019 · AI
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$502,619Nir Hacohen · Broad Institute, Inc. · R01 · FY2019 · CA
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
$502,591Manuel L Penichet · University Of California Los Angeles · R01 · FY2017 · CA
CHI3L1-targeted small molecules for glioblastoma
$502,588Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
CHI3L1-targeted small molecules for glioblastoma
$502,588Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS
Targeted Inhibition in Leukemia
$502,537Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA
Systems analysis of mechanisms driving response to immunotherapy in clear cell cancers
$502,504Andrew J. Gentles · Stanford University · U01 · FY2023 · CA
The c-Rel Checkpoint for Immunosuppression and Immunotherapy
$502,487Warren S Pear · University Of Pennsylvania · R01 · FY2022 · AI